Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Mar 08, 2021

SELL
$4.37 - $9.46 $108,218 - $234,267
-24,764 Closed
0 $0
Q3 2020

Dec 02, 2020

BUY
$8.56 - $26.93 $20,235 - $63,662
2,364 Added 10.55%
24,764 $224,000
Q2 2020

Sep 04, 2020

BUY
$21.21 - $31.55 $475,104 - $706,720
22,400 New
22,400 $616,000

Others Institutions Holding TCDA

About Tricida, Inc.


  • Ticker TCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,668,900
  • Market Cap $557K
  • Description
  • Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...
More about TCDA
Track This Portfolio

Track Teachers Retirement System Of The State Of Kentucky Portfolio

Follow Teachers Retirement System Of The State Of Kentucky and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teachers Retirement System Of The State Of Kentucky, based on Form 13F filings with the SEC.

News

Stay updated on Teachers Retirement System Of The State Of Kentucky with notifications on news.